SCHEMBL20118396

SCHEMBL20118396

CC1=NN(c2ccncc2Cl)C(=O)C12CCC(N1C(=O)c3ccccc3C1=O)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
BCL2A1 Q16548 1/20 0.33
LMNA P02545 2/20 0.33
RORC P51449 1/20 0.33
GFER P55789 1/20 0.33
ALDH1A1 P00352 3/20 0.32
CCNC P24863 3/20 0.32
CDK8 P49336 3/20 0.32
TDP1 Q9NUW8 2/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
STAT3 P40763 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20118162 0.83 KMT2A (0.40) ADRA1DADRA1AADRA1BL3MBTL1MKNK1
SCHEMBL20118057 0.82 BCL2A1 (0.34) BCL2A1
SCHEMBL20118239 0.82 BCL2A1 (0.34) BCL2A1
SCHEMBL20118234 0.79 BCL2A1 (0.37) MKNK1MKNK2BCL2A1LMNACCNC
SCHEMBL18208163 0.72 ADRA1D (0.39) ADRA1DADRA1AADRA1BL3MBTL1MKNK1
SCHEMBL20118395 0.71 KMT2A (0.39) ADRA1DADRA1AADRA1BL3MBTL1MKNK1
SCHEMBL20118233 0.69 KDM4E (0.49) KDM4E
SCHEMBL20118216 0.66 L3MBTL1 (0.40) L3MBTL1ALDH1A1TDP1GAAKDM4E
SCHEMBL19132697 0.66 RORC (0.47) ADRA1DADRA1AADRA1BL3MBTL1LMNA
SCHEMBL20118108 0.64 PSEN1 (0.35) ALDH1A1GAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018078009-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed